Acasti Pharma (ACST) Lifted to Buy at ValuEngine

Share on StockTwits

ValuEngine upgraded shares of Acasti Pharma (NASDAQ:ACST) from a hold rating to a buy rating in a research note released on Wednesday.

Shares of ACST stock opened at $1.00 on Wednesday. Acasti Pharma has a 1 year low of $0.43 and a 1 year high of $3.36. The firm has a market cap of $41.82 million, a PE ratio of -1.32 and a beta of 1.40. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.35 and a current ratio of 1.35.

Acasti Pharma (NASDAQ:ACST) last issued its quarterly earnings results on Tuesday, August 14th. The biopharmaceutical company reported ($0.18) earnings per share (EPS) for the quarter. As a group, research analysts expect that Acasti Pharma will post -0.7 earnings per share for the current year.

Acasti Pharma Company Profile

Acasti Pharma Inc, a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia.

Further Reading: Book Value Per Share – BVPS

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks: Analysts Anticipate Clorox Co  Will Announce Quarterly Sales of $1.48 Billion
Zacks: Analysts Anticipate Clorox Co Will Announce Quarterly Sales of $1.48 Billion
Solaris Hits 1-Day Volume of $2,100.00
Solaris Hits 1-Day Volume of $2,100.00
Analysts Anticipate BIO-TECHNE Corp  Will Post Earnings of $1.00 Per Share
Analysts Anticipate BIO-TECHNE Corp Will Post Earnings of $1.00 Per Share
Talos Energy Inc  Expected to Post Quarterly Sales of $276.35 Million
Talos Energy Inc Expected to Post Quarterly Sales of $276.35 Million
ITV  Hits New 52-Week Low at $125.50
ITV Hits New 52-Week Low at $125.50
Stellar Holdings  Price Tops $0.0001 on Exchanges
Stellar Holdings Price Tops $0.0001 on Exchanges


© 2006-2018 Ticker Report